Enlaces de acceso:
CONTENIDO
Destacados
-
A multidisciplinary approach for the identification of novel HIV-1 non-nucleoside reverse transcriptase inhibitors: S-DABOCs and DAVPs.
Radi, M., Falciani, C., Contemori, L., Petricci, E., Maga, G., Samuele, A., Zanoli, S., Terrazas, M., Castria, M., Togninelli, A., Esté, J.A., Clotet-Codina, I., Armand-Ugón, M., Botta, M.ChemMedChem 3, 573-593
-
Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells
Massanella, M., Puigdomenech, I., Cabrera, C., Fernandez-Figueras, M. T., Aucher, A., Gaibelet, G., Hudrisier, D., Garcia, E., Bofill, M., Clotet, B., and Blanco, J.Aids 23, 183-188
-
New molecular method for the detection of human papillomavirus type 16 integration.
Canadas, M. P., Darwich, L., Sirera, G., Cirigliano, V., Bofill, M., Clotet, B., and Videla, S.Clin Microbiol Infect.
-
Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs.
Fumaz, C. R., Munoz-Moreno, J. A., Molto, J., Ferrer, M. J., Lopez-Blazquez, R., Negredo, E., Paredes, R., Gomez, G., and Clotet, B.AIDS Care 20, 796-805.
-
Update of the Drug Resistance Mutations in HIV-1.
Johnson, V. A., Brun-Vezinet, F., Clotet, B., Gunthard, H. F., Kuritzkes, D. R., Pillay, D., Schapiro, J. M., and Richman, D. D.Top HIV Med. 2008 Mar-Apr; 16(1):62-8.
